Index Investing News
Sunday, May 24, 2026
No Result
View All Result
  • Login
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
No Result
View All Result
Index Investing News
No Result
View All Result

Fulcrum Therapeutics, Inc. (FULC) This fall 2024 Earnings Name Transcript

by Index Investing News
February 26, 2025
in Stocks
Reading Time: 2 mins read
A A
0
Home Stocks
Share on FacebookShare on Twitter


Fulcrum Therapeutics, Inc. (NASDAQ:FULC) This fall 2024 Earnings Convention Name February 25, 2025 8:00 AM ET

Firm Individuals

Alex Sapir – President & CEO
Alan Musso – CFO
Iain Fraser – SVP, Early Growth

Convention Name Individuals

Rick Miller – Cantor Fitzgerald
Joseph Schwartz – Leerink Companions
Matthew Biegler – Oppenheimer
Edward Tenthoff – Piper Sandler
Anish Nikhanj – RBC Capital

Operator

Good morning, and welcome to Fulcrum Therapeutics Fourth Quarter and Full 12 months 2024 Monetary Outcomes and Enterprise Replace Convention Name. At present, all contributors are in listen-only mode. This name is being webcast stay and will be accessed on the Buyers part of Fulcrum’s web site at www.fulcrumtx.com and is being recorded.

Please be reminded that remarks throughout this name might include forward-looking statements throughout the that means of the Non-public Securities Litigation Reform Act of 1995. Could embrace statements in regards to the firm’s future expectations and plans, scientific growth time traces and monetary projections. Whereas these forward-looking statements characterize Fulcrum’s views as of at the moment, this shouldn’t be relied upon as representing the corporate’s views sooner or later.

Fulcrum might replace these statements sooner or later, however will not be taking up any obligation to take action. Please seek advice from Fulcrum’s most up-to-date filings with the Securities and Trade Fee for discussions of sure dangers and uncertainties related to the corporate’s enterprise.

Main the decision at the moment shall be Alex Sapir, CEO and President of Fulcrum. Becoming a member of Alex on the decision are Alan Musso, Chief Monetary Officer; and Dr. Iain Fraser, Senior Vice President of Early Growth. After offering updates on the corporate’s key applications, there shall be a short Q&A, by which Alex, Alan, and Iain shall be out there to reply your questions.

With that, it is my pleasure to show the decision over to Alex.

Alex Sapir

That is nice. Thanks a lot, Marvin. Good morning, everybody, and thank



Source link

Tags: CallEarningsFULCFulcrumTherapeuticsTranscript
ShareTweetShareShare
Previous Post

Not Time To Purchase But? Bitcoin Faces Strain As Commonplace Chartered Predicts Additional 10% Drop

Next Post

JD Vance was proper to tear into Europe’s muzzling the voice of the folks

Related Posts

Lululemon: The Sell-Off Is Overdone, But Don’t Fall In Love With The Stock (NASDAQ:LULU)

Lululemon: The Sell-Off Is Overdone, But Don’t Fall In Love With The Stock (NASDAQ:LULU)

by Index Investing News
May 23, 2026
0

This article was written byFollowI am an investment professional with over 7 years of experience spanning quant equities, asset management,...

Friday File: Portfolio Construction in a Time of Greed and Fear

Friday File: Portfolio Construction in a Time of Greed and Fear

by Index Investing News
May 19, 2026
0

Irregulars Quick Take Paid members get a quick summary of the stocks teased and our thoughts here. Join as a...

Berkshire shares trade lower even after Abel scores good marks at meeting, earnings jump

Berkshire shares trade lower even after Abel scores good marks at meeting, earnings jump

by Index Investing News
May 11, 2026
0

Greg Abel, CEO of Berkshire Hathaway, speaks during the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska, May 2, 2026.CNBCBerkshire...

The S&P 500 Dividend Yield Just Hit An All-Time Low – Meb Faber Research

The S&P 500 Dividend Yield Just Hit An All-Time Low – Meb Faber Research

by Index Investing News
May 7, 2026
0

The S&P 500 dividend yield just hit an all-time low of 1.08%, the lowest since the 1800s. The prior low...

AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline By Reuters

AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline By Reuters

by Index Investing News
April 29, 2026
0

By Kamal Choudhury and Christy Santhosh April 29 (Reuters) - on Wednesday reported better-than-expected quarterly revenue and profit, fueled by...

Next Post
JD Vance was proper to tear into Europe’s muzzling the voice of the folks

JD Vance was proper to tear into Europe's muzzling the voice of the folks

Ukraine and US agree on uncommon earth minerals deal

Ukraine and US agree on uncommon earth minerals deal

RECOMMENDED

Who thought this was a good suggestion? Walmart pulls its tasteless ‘Juneteenth’ celebratory ice cream

Who thought this was a good suggestion? Walmart pulls its tasteless ‘Juneteenth’ celebratory ice cream

May 28, 2022
2 Reliable Dividend Stocks For An Undeniable Demographic Trend

2 Reliable Dividend Stocks For An Undeniable Demographic Trend

April 21, 2023
“Snowballing” to 12 Doorways in 4 Years & Changing TWO Six-Determine Salaries

“Snowballing” to 12 Doorways in 4 Years & Changing TWO Six-Determine Salaries

July 27, 2024
Iowa’s Caitlin Clark delivers a performance for the ages

Iowa’s Caitlin Clark delivers a performance for the ages

April 2, 2023
Weaponising water in Palestine | Israel-Palestine conflict

Weaponising water in Palestine | Israel-Palestine conflict

July 27, 2023
With Russian Cutoff Feared, Europeans Are Instructed to Curb Pure Gasoline Use

With Russian Cutoff Feared, Europeans Are Instructed to Curb Pure Gasoline Use

July 21, 2022
Arexvy Puts GSK Stock Back On The Growth Prescription (Rating Upgrade) (NYSE:GSK)

Arexvy Puts GSK Stock Back On The Growth Prescription (Rating Upgrade) (NYSE:GSK)

November 3, 2023
Trump warns of tariff ‘disturbance’ as he touts commerce plans

Trump warns of tariff ‘disturbance’ as he touts commerce plans

March 5, 2025
Index Investing News

Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.

  • 1717575246.7
  • Browse the latest news about investing and more
  • Contact us
  • Cookie Privacy Policy
  • Disclaimer
  • DMCA
  • Privacy Policy
  • Terms and Conditions
  • xtw18387b488

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In